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Medical revalidation was introduced 
in the United Kingdom in 2012, 
following more than a decade of 
protracted debate concerning the 
appropriate methods for ensuring the 
quality and safety of medical practice. 
This debate reflected changing wider 
societal notions of accountability 
and of quality improvement in health 
care.1–4 Revalidation requires doctors to 
demonstrate on a regular basis that they 
are up-to-date and fit to practice, by 
bringing a portfolio of evidence (called 
supporting information) of continuous 
professional development (CPD), 
peer and patient feedback, quality 
improvement or audit, and significant 
events to their annual appraisal. The 
revalidation and appraisal framework 
is based on “Good Medical Practice” 
(GMP), the core guidance for doctors 
published by their professional 
regulator, the General Medical Council 
(GMC). This consists of four domains 
of performance: knowledge, skills, 
and performance; safety and quality; 
communication, partnership, and 
teamwork; and maintaining trust. 
GMP requires that doctors should 
be “regularly reflecting on [their] 
standards of practice and the care [they] 
provide.”5 Evidence of this reflection 
is a key component of revalidation. 
Every five years a “responsible officer” 
(RO), a senior doctor employed by 
each health care organization, makes 
a revalidation recommendation to the 
GMC. Doctors who do not engage 
with revalidation can, ultimately, lose 
their license to practice. In the United 
Kingdom the medical licensing system 
is run by the GMC, which holds two 
registers of those eligible to work in 
the UK health service, the Specialist 
and General Practise (GP) Registers, 
and doctors must be registered on one 
or both of these. The medical Royal 
Colleges in the United Kingdom are 
responsible for setting standards within 
their field and for supervising the 
training of doctors within that specialty. 
Internationally, revalidation is most 
similar to New Zealand’s practicing 
certificate and recertification and the 
American maintenance of licensure and 
certification.6–8 The implementation of 
revalidation commenced in December 
2012, with the intention that all doctors 
in the United Kingdom would have 
undergone revalidation by March 2016.
Revalidation signals a fundamental 
change in how the medical profession 
is regulated and is a complex new 
intervention that has evoked considerable 
critical debate amongst health care 
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professionals.4,9,10 There has been much 
deliberation and divergence of opinion 
over the purposes of revalidation and 
a dichotomy within the debate over 
whether revalidation should or could 
serve what might be termed the purposes 
of regulation or of professionalism.11–13 
Professionalism has been variously 
defined but can be explained as a model 
where the organization of, and control 
over, work is fulfilled by the profession 
itself instead of by the market or by 
some form of administrative hierarchy.14 
It is underpinned by a progressive, 
intrinsically motivated ambition to define 
and drive up quality standards. In this 
context, it is used to refer to the notion 
that revalidation should seek to raise 
professional standards by capitalizing on 
the intrinsic motivations of doctors as 
professionals, for example, by increasing 
involvement in CPD and fostering quality 
improvement activities. Regulation 
conversely can be defined as sustained 
and focused control over activities 
valued by society, which is exercised by 
a public agency.15 It can be understood 
as primarily a retrospective summative 
assessment of performance16 and in 
this context is largely concerned with 
whether or not doctors meet minimum 
standards and are safe and fit to practice. 
It is an extrinsic process, shaped mainly 
by notions of accountability. Various 
elements of these two contrasting 
perspectives are considered in the 
literature.2,11,17,18
Previous research found professionalism 
and regulation to be competing 
discourses within the professional and 
revalidation policy-making community 
when plans for revalidation were being 
developed in 2011, but had not yet been 
introduced.11 This diversity of opinion 
regarding the purpose of revalidation 
was identified as potentially problematic 
for the development and successful 
implementation of the policy.11 It was 
noted, however, that “revalidation policy 
has always been a product in and over 
time, and it must be acknowledged that 
our interviews may represent only one 
moment in this time continuum.”11(p92) In 
this study, by analyzing key stakeholder 
interviews at different points in time 
before and during the implementation 
of revalidation, we expand on this line of 
enquiry and explore how these competing 
discourses have developed, and how the 
purposes of revalidation have evolved.
Method
We undertook a qualitative investigation 
of the initial stages of implementing 
revalidation in the United Kingdom 
between 2011 and 2015, from the 
perspective of those who were 
responsible for its development and 
early implementation. We conducted 71 
interviews with a purposeful sample of 
60 UK policy makers and senior leaders 
at three different points during the 
development and implementation of 
revalidation: 31 in 2011, 26 in 2013, and 
14 in 2015. Participants were recruited 
purposively because of their role 
organizationally or their involvement in 
the development of medical revalidation. 
We approached them by e-mail with no 
compensation for involvement in the 
study being given. Interviews typically 
lasted between 45 and 60 minutes. 
The first two interview sets were all 
conducted face-to-face and the third set 
face-to-face or by telephone, according 
to participant preferences. The first set 
of interviews, from 2011, was conducted 
prior to the introduction of revalidation; 
the second set in 2013, shortly after the 
introduction of revalidation, and the 
final set in 2015, once the process of 
implementation had been under way 
for three years. A discourse analysis of 
the 2011 interviews has previously been 
presented.11 The topic guides across all 
three interview sets focused around three 
main areas: individual roles in relation to 
revalidation; interviewees’ understanding 
of revalidation, its purpose, and aims; 
and predictions or experiences of 
revalidation’s impact (see Supplemental 
Digital Appendix 1 at http://links.lww.
com/ACADMED/A501). The first two 
interview sets also included a section 
on the measurement and evaluation of 
revalidation, as they were part of the 
development of an evaluative framework 
for revalidation.
The interviewees were all key actors in the 
development and design of revalidation, 
with 11 participants being interviewed 
at two time points and 49 interviewed 
once. No participant was interviewed at 
all three data points because of changes 
to senior involvement over a five-year 
period. The participants’ affiliations to 
organizations are summarized in Chart 1.
To assist the organization of data, 
we digitally recorded interviews, 
transcribed them, and then imported 
them into Dedoose qualitative data 
analysis software (SocioCultural 
Research Consultants, Los Angeles, 
California). Transcripts were encrypted 
and stored securely, so they did 
not need anonymizing. Interview 
transcripts were coded by two members 
of the research team (A.T. and J.F.) 
using a directed content analysis 
approach.19 We developed a coding 
framework based on previous findings 
from our earlier analysis of the 2011 
interview set. It was structured to 
explore what participants understood to 
be the purpose of revalidation and how 
the previously identified discourses of 
professionalism and regulation featured 
within their narratives. Following 
coding, two members of the research 
team (A.T. and J.F.) analyzed the data 
across the three interview stages, using 
the constant comparative method,20 to 
understand changes and continuities 
over time. We enhanced rigor and 
trustworthiness of the data analysis 
through researcher triangulation. 
Throughout its development, the 
coding framework was discussed with 
all the team members, as were the 
themes and findings that arose from it. 
A few minor disagreements occurred 
regarding decisions, and these were 
resolved through consensus discussion. 
Initial coding was also verified across 
two researchers (A.T. and J.F.) to 
ensure consistency of the framework’s 
application.
Ethical approval for this study was 
awarded by the Peninsula College of 
Medicine & Dentistry research ethics 
committee (no. 12/13-122), by the 
Plymouth University Faculty of Health 
and Human Sciences & PSMD Research 
Ethics Committee (no. 15/16-486), and 
by the University of Manchester ethics 
committee (REC 15028).
Results
To demonstrate how the key discourses 
concerning revalidation have evolved 
over time, we have organized our findings 
chronologically, and identify both areas 
of continuity and of change during the 
period in which revalidation was being 
introduced and implemented.
2011
As was noted earlier, two dominant 
discourses about the purposes of 
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revalidation were identified in the 
interviews in 2011, which we termed 
professionalism and regulation. 
While these purposes were discussed 
simultaneously in many participants’ 
narratives, a perceived conflict or 
incompatibility between professionalism 
and regulation was articulated as a 
concern by the majority of interviewees. 
This incompatibility or conflict featured 
in different ways within the 2011 
interviews. For some, the two purposes 
were presented as distinct and in 
competition:
What it is not, which some of the Colleges 
have been looking at, is driving up the 
standards. It is actually about assuring 
the standard. Driving up standards is 
professional development and everything 
else. Revalidation is ensuring that people 
do not fall below a particular minimum 
standard level.… We are not looking for 
excellence in revalidation; we are looking 
to make sure that people are OK and safe. 
(2011)
[The government] did want to bring 
doctors down a peg or so, there was this 
feeling that they are prima donnas and 
that they do what they want and so on. 
I think there were many attempts to try 
and, for want of a better word, bring them 
down a peg or two. I think that whilst they 
saw revalidation as a tool it was a part of 
the range of things that they did.… That 
was the approach used: regulation. (2011)
For others, though both purposes were 
acknowledged, their separateness was 
articulated and the differences between 
them were emphasized. For example, 
some thought the purpose of revalidation 
had changed, from the identification 
of poor performance to promoting 
professionalism and standards of 
practice. In these narratives, there was 
a presumption that the two purposes 
would not or could not coexist:
What we were originally told would be a 
basic quality assessment that almost every 
doctor should pass, except the really bad 
ones who really needed remediation, was 
being turned round into a scheme that 
appeared determined to identify those 
doctors who were paragons of practice, 
those doctors who exemplified all of 
the attributes required of a doctor and 
exemplified them at high level. (2011)
The thing about it is it was always designed 
to try and recognize another Shipman* 
early, but it will never do that of course. 
Things have moved on from that. Now 
it is designed to raise standards across 
the board by establishing what is the 
recognized standard practice and ensuring 
that everybody fulfills that…. So I think 
revalidation is designed to try and improve 
medical practices’ standards across the 
board but it is not, and it should not be 
regarded as, just a way of looking for bad 
apples because that is very difficult. (2011)
Moreover, some interviewees thought 
that the two purposes were detrimental to 
each other, with the achievement of one 
seen as negatively affecting the ability to 
achieve the other:
By and large I think the public see this as 
screening excluding those not fit-for-
purpose [sic] and the profession sees it as 
shifting the curve to the right. I could go 
on and on about this … but essentially 
the mechanisms you use for one are not 
necessarily the mechanisms you use for 
the other. One process has to be formative 
and the other is summative and one of the 
dangers of our current position is that we 
are trying to use the single system to be 
both formative and summative and that is 
not easy to do. (2011)
*Harold Shipman was a British general practitioner 
found guilty of murdering 15 of his patients in 2000. 
In the wake of his conviction, much of Britain’s legal 
structure concerning health care and medicine was 
reviewed.
Chart 1
Interviewee Organization Affiliation, From a Study Evaluating the Development of 
Medical Revalidation in the United Kingdom, 2011–2015
2011 2013 2015
Organization No. Organization No. Organization No.
BMA 2 Academy of Medical 
Royal Colleges
1 Care Quality 
Commission
2
Court of Appeals 1 BMA 1   
Department of Health 1 GMC 1 Health Education 
England
1
GMC 3 GP practices 1 GMC 1
Independent Doctors 
Federation
1 Health Education 
England
1 Independent sector 2
Independent sector 1 Health Watch and 
Public Involvement 
Association
1 Lay representatives 
for Revalidation 
Advisory Board 
(formerly RIAB)
1
National Clinical 
Assessment Service 
(NCAS)
1 Independent Health 
Advisory Service
1 Monitors 1
NHS Confederation 1 Independent sector 3 NHS clinical 
commissioners
1
NHS employers 2 Locum agencies 2 NHS employers 1
NHS Health Trust 1 NHS England 1 NHS England 2
NHS Professionals 1 NHS hospitals 3 Royal College of 
Psychiatrists
1
Revalidation Delivery 
Board
1 Patient liaison 
groups
1 RST 1
RIAB 1 RIAB 4
Royal College of 
Anaesthetists
1 Royal College of 
Anaesthetists
1
Royal College of  
General Practitioners
2 Royal College of 
Psychiatrists
1
Royal College of 
Pathologists
1 UK universities 1
RST 1 Wales Deanery 2
Scottish Government 2
Strategic Health 
Authority
1
UK universitiesa 6
 Abbreviations: BMA indicates British Medical Association; GMC, General Medical Council; NHS, National 
Health Service; RIAB, Revalidation Implementation Advisory Board; RST, Revalidation Support Team; GP, general 
practitioner.
 aProfessors of medicine, general practice, health policy, medical education, and surgery.
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There is a tension…. There is the really 
supportive element of appraisal and 
potential revalidation as well as the 
more objective summative assessment 
process.… I think we have got a bit of 
work to do to be able to make clinical 
physicians confident that if they do 
genuinely have anxieties or concerns that 
they have a way of expressing those but 
that it will not necessarily have a major 
impact on their initial appraisal outcome 
until some of these issues have been dealt 
with. (2011)
2013
By 2013, when the implementation of 
revalidation was under way and many 
interviewees now had some experience 
of the process (often both in leading 
revalidation and in being revalidated 
themselves), professionalism and 
regulation still featured as the two 
dominant purposes of revalidation. But 
the experience of engaging in revalidation 
seemed to have altered some interviewees’ 
understandings of the relationship between 
the two purposes. Some interviewees 
still spoke of the two purposes as either 
distinctly separate or in conflict:
If the system’s not picking out the poorly 
performing doctors then the system’s not 
working … one of the primary purposes 
of the system is to identify poorly 
performing doctors. (2013)
What I think it will do is it will drive 
quality up because I think what it requires 
doctors to do is to reflect on their practice 
and in so doing it should, at the end of 
the day, ensure that a doctor is practicing 
within their competencies and is 
operating against a quality framework in 
whatever their specialized area is whether 
a GP or a specialist. (2013)
The trouble with revalidation is it’s trying 
to combine two things; in the old days 
appraisal was more about things like 
mentoring or supervision where the idea it 
was a safe environment … now it’s got a big 
performance management component to it 
and I’ve never been convinced that you can 
safely combine those into one. (2013)
However, many more participants 
began to speak of the two purposes 
as necessarily coexisting, often with 
a pragmatic recognition that both 
were needed in practice. Overall, the 
fundamental tensions or conflicts 
between them anticipated by the majority 
of participants in 2011 seemed not to 
have materialized in practice. There 
was now a growing view that these 
purposes might coexist, and there was 
some reframing of the earlier dichotomy 
between dealing with “poor” performance 
and promoting professionalism.
 I do think revalidation is a regulatory 
mechanism to ensure proper standards 
[minimum standards] in the practice of 
medicine. I think it’s a—I think building 
on what I said earlier it was and can be and 
should be a means to ensure that people 
don’t just keep their nose down day to 
day doing clinical work without reflecting 
how to improve, without reflecting how to 
make things better. (2013)
I think even y’know in the last two 
three years [the profession] have 
become much more aware of doctors 
who are not performing prop[erly], 
not performing well, it’s and trying to 
develop other doctors with the skills to 
be able to manage doctors well, and that 
performance management is going to be 
quite a challenge but I think it can happen 
and revalidation is really the springboard 
for ensuring that that takes place. (2013)
I think it’s really to hold doctors and 
indeed employers responsible for making 
sure there are policies and procedures in 
place to make sure doctors are looking 
at their own practice and undertaking 
activities to keep themselves up-to-date 
and improve their practice it’s um to 
make sure we’ve all got policies and 
procedures in place for handling concerns 
about doctors and mechanisms for 
capturing feedback … it’s about someone 
casting their eye over and making a 
sound judgment it’s about making us all 
accountable. (2013)
2015
The final set of interviews was conducted 
in 2015 once the implementation of 
revalidation had been under way for 
three years, and at a point when almost 
half of doctors in the United Kingdom 
had been through their first experience 
of revalidation. Participants at this 
stage were far more familiar with how 
revalidation worked and experienced in 
the processes it involved. There were still 
some perceived tensions between the 
professional and regulatory purposes of 
revalidation, and the ability of processes 
like appraisal to serve both purposes:
I think hence doctors who have to get 
through their revalidation portfolio, 
and [need] their recommendation to be 
positive, I think are possibly sanitizing 
their reflections, and being less reflective, 
less self-critical than maybe they should 
be. Or, if the rhetoric of revalidation 
would be that it’s a place to reflect, they 
are worried that if their reflection is too 
critical … they may actually water down 
their reflection just enough to be engaged, 
but not too much. (2015)
There is a danger through revalidation that 
the appraisal gets a bit dumbed down to 
the basics and it becomes almost a sort of 
tick-box exercise, have you got 50 credits, 
two significant events, and have you done 
an audit in the last five years, patient 
survey and colleague feedback? (2015)
However, the 2015 interviews in general 
seemed to show that interviewees had 
found that these two purposes could 
be reconciled in practice. Both were 
frequently cited as dual aims needing to 
be met for revalidation to be considered 
a success. Revalidation was often situated 
as having or requiring a two-pronged 
approach:
I think a lot of the value in revalidation is 
in the ability of reflection and a strength 
of sort of governance system with that to 
really provide doctors with an opportunity 
to develop and improve. (2015)
So for NHS [National Health Service] 
doctors, doctors in large, independent 
hospitals, they’re probably used to having 
a management appraisal. For doctors 
in primary care, they’re probably very 
used to having an appraisal that is very 
supportive and developmental. And 
through revalidation, we’ve now got 
a system which is a bit of both. So it 
attempts to make judgments about the 
quality of the doctor’s practice and is also 
supportive and developmental. (2015)
The hold to account was more to do 
with making sure that people meet the 
requirement of the GMC in terms of 
good medical practice, but the skills are 
more about reflection and facilitating 
appraisees, you know, to recognize that 
they may well be producing evidence 
to support good practice but as well as 
that they need to look to see whether 
the evidence that they are producing is 
helpful, whether they need to address any 
areas. (2015)
Some participants went further than 
seeing professionalism and regulation 
as coexisting dual purposes of 
revalidation, and suggested that they 
were interconnected, and even somewhat 
codependent.
So it’s formalized … the whole process 
that was already happening in much more 
of an ad hoc way.… That is a good thing 
because I firmly believe that revalidation 
has improved the quality and the 
professionalism of doctors in this country 
because it’s forced the issue, whereas before 
it was much more voluntarily. (2015)
The doctor has to demonstrate, to the 
extent the system demands of him or 
her, that he is a suitable, if you like, 
Research Report
Academic Medicine, Vol. XX, No. X / XX XXXX 5
suitable to practice. That’s quite different 
from a model in which the regulator 
only deals with those situations in 
which there’s a strongly suspected view 
that the doctor isn’t fit to. It moves it 
from reacting to only when there’s a 
problem, to proactively trying to stop 
problems occurring, and broadly, 
improve standards … it drives them in 
the right direction across the board. So 
it’ll drive them in the right direction in 
terms of people’s capability, their clinical 
competence, it’ll drive them in the right 
direction in terms of probity. (2015)
I think the RO regulations more or 
less force a better quality appraisal 
conversation because it’s at its heart. It’s a, 
sort of, performance management system 
where if we’re appraising one another, 
as it were, we do have somebody then 
saying, well, what was the outcome there 
and we can’t recommend relicensing 
over the five-year cycle. The Responsible 
Officer themselves are then under quite 
noticeable external scrutiny by their own 
RO and in due course by the General 
Medical Council accepting or rejecting the 
recommendations that they make. (2015)
Discussion
Our analysis of revalidation stakeholder 
interviews undertaken in 2011, 2012, 
and 2015 found that, with regard 
to the purpose of revalidation, two 
main discourses were present across 
the implementation period under 
investigation: professionalism and 
regulation. However, the nature of the 
relationship between the two purposes and 
the way they were described has changed 
over time, with the separate discourses 
converging, and early concerns about 
actual or potential conflict being replaced 
by perceptions of coexistence or even 
codependency. Before the implementation 
of revalidation, many stakeholders 
articulated fundamental concerns 
about a conflict between these two 
purposes, emphasized their differences, 
and expressed doubts about which 
might prevail, or whether revalidation 
could serve both purposes. During the 
implementation of revalidation, the 
relationship between these purposes began 
to change, and it seems that the experience 
of “doing” revalidation led stakeholders 
to find that they could at least coexist 
without too much dissonance in practice. 
Indeed, some stakeholders began to see 
the dichotomy between professional 
and regulatory purposes as somewhat 
artificial, and to argue that dealing with 
concerns about poor practice and seeking 
to improve professional standards were 
complementary and even codependent 
purposes.
The introduction of revalidation has 
been the most significant change 
in medical regulation in the United 
Kingdom in many decades, and has 
involved a fundamental reconfiguration 
of the relationships between doctors, the 
organizations in which they work, and the 
professional regulator, the GMC. Before 
the implementation of revalidation, 
there were many calls to define and 
clarify its purpose.9,21 But it seems that, 
in part because this was a contentious 
reform, there was considerable (perhaps 
necessary) ambiguity about its purpose or 
purposes and the way its implementation 
might affect the medical profession 
and its notions of professionalism and 
accountability. In practice, the concern 
that revalidation might subvert or 
undermine professionalism, replacing 
its intrinsic values and purposes with 
a set of extrinsic ones imposed by 
society or government, does not seem 
to have been realized. Rather, it seems 
that, for senior medical leaders and 
revalidation stakeholders, a way has been 
found to adapt the conceptualization 
of professionalism and professional 
regulation to enable the acceptance and 
incorporation of revalidation.
The process of evolution in the purposes 
of medical regulation and the nature 
of medical professionalism that we 
have observed is far from new, and 
empirical sociological accounts of how 
doctors were regulated in the 1990s22,23 
vividly demonstrate how much has 
changed over the last three decades. The 
medical profession has accepted and 
incorporated a series of innovations in 
governance, accountability, performance 
measurement, and regulatory oversight 
which may seem at odds with traditional 
ideas of professional self-regulation. 
These reforms have been accepted and 
even embraced or advocated by elites and 
leaders of the profession as a necessary 
means to enhance professionalism while 
retaining professional control. The 
introduction of revalidation has been 
positioned as the latest step in satisfying 
public and political expectations of 
accountability from the profession while 
also being an act of professionalism in 
itself, because it demonstrates an intrinsic 
motivation to improve professional 
standards and ensure the quality of 
medical care. From this perspective, a 
reconfigured notion of professionalism 
thus assumes that individual doctors 
acknowledge the need for themselves 
to be held accountable and accept that 
revalidation is the means by which this 
accountability is enacted.
As the first cycle of medical revalidation 
comes toward completion, the GMC 
is consulting on how the practical 
implementation of revalidation might be 
improved,24 but the principle that doctors 
should be required to demonstrate 
periodically that they are fit to practice 
has moved from being a contentious 
proposal which met with much 
opposition in the decade before it was 
introduced, to being largely accepted in 
principle and in practice.
Limitations
Our findings are based on qualitative 
interviews with elite stakeholders and 
members of the profession involved in 
the development of revalidation. The 
position of these individuals may mean 
that to fulfill their roles, greater buy-in 
is needed than the wider profession, 
and so the generalizability of the views 
presented in this paper may be to a 
degree limited. This research points to 
the need for further investigation into the 
practice of revalidation, with a focus on 
the experiences and perspectives of those 
engaged with the policy at different levels 
of the profession.
Conclusion
The changing nature of the discourse 
about revalidation during the period 
of its implementation suggests that 
as organizations and professionals 
engaged with and experienced the 
realities, early concerns about adverse 
consequences were not borne out. 
Moreover, it seems that the effective 
implementation of revalidation 
involved a necessary reconciliation of 
professional and regulatory narratives 
in ways that have embedded notions of 
accountability and regulatory oversight in 
a redefined, modern conceptualization of 
professionalism.
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